Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
22,375.00
+425.00
+(1.94%)
At close: February 28 at 4:59:07 PM GMT-3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
21,468,000
21,468,000
13,006,000
19,095,000
14,109,000
Investing Cash Flow
-7,734,000
-7,734,000
-14,083,000
-4,960,000
-16,555,000
Financing Cash Flow
-7,032,000
-7,032,000
-4,810,000
-9,119,000
2,593,000
End Cash Position
13,318,000
13,318,000
6,909,000
12,773,000
8,167,000
Capital Expenditure
-3,372,000
-3,372,000
-3,863,000
-4,388,000
-4,448,000
Issuance of Debt
3,599,000
3,599,000
5,939,000
--
7,936,000
Repayment of Debt
-1,290,000
-1,290,000
-1,755,000
-2,251,000
-2,319,000
Repurchase of Capital Stock
-1,306,000
-1,306,000
-1,346,000
--
-840,000
Free Cash Flow
18,096,000
18,096,000
9,143,000
14,707,000
9,661,000
12/31/2021 - 12/27/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BRM.MU Bristol-Myers Squibb Co
56.83
+3.29%
AZN.BA AstraZeneca PLC
46,250.00
+0.60%
AMGN.MX Amgen Inc.
6,032.00
0.00%
ABBV34.SA AbbVie Inc.
76.22
+2.32%
AMGN.BA Amgen Inc.
12,500.00
+0.81%
GILD.BA Gilead Sciences, Inc.
35,000.00
+2.26%
YPHA.F Astellas Pharma Inc.
9.05
-1.09%
BIIB.BA Biogen Inc.
13,125.00
0.00%
0Q1N.IL Pfizer Inc.
25.95
-0.76%
OZTA.SG Grifols SA
10.43
+0.29%